$403 Million is the total value of Tri Locum Partners LP's 35 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 106.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WBA | New | WALGREENS BOOTS ALLIANCE INCput | $42,273,000 | – | 770,000 | +100.0% | 10.48% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INCcall | $42,273,000 | – | 770,000 | +100.0% | 10.48% | – |
| REGN | Buy | REGENERON PHARMACEUTICALS | $30,615,000 | +508.0% | 64,705 | +520.8% | 7.59% | +315.1% |
| MDT | Buy | MEDTRONIC PLC | $28,309,000 | +18.4% | 239,644 | +17.4% | 7.02% | -19.2% |
| JNJ | Buy | JOHNSON & JOHNSON | $27,715,000 | +8.3% | 168,634 | +3.7% | 6.87% | -26.1% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $27,007,000 | – | 293,426 | +100.0% | 6.70% | – |
| BAX | Buy | BAXTER INTL INC | $26,494,000 | +10.5% | 314,136 | +5.2% | 6.57% | -24.5% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $24,683,000 | +9393.5% | 390,992 | +9216.0% | 6.12% | +6411.7% |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $21,951,000 | +24.7% | 399,842 | -9.4% | 5.44% | -14.8% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $18,143,000 | – | 110,382 | +100.0% | 4.50% | – |
| HUM | New | HUMANA INC | $14,964,000 | – | 35,693 | +100.0% | 3.71% | – |
| NUAN | New | NUANCE COMMUNICATIONS INC | $14,553,000 | – | 333,482 | +100.0% | 3.61% | – |
| LLY | Sell | LILLY ELI & CO | $9,023,000 | -3.7% | 48,299 | -13.0% | 2.24% | -34.3% |
| NMTR | Buy | 9 METERS BIOPHARMA INC | $7,774,000 | +550.5% | 6,644,337 | +377.7% | 1.93% | +344.2% |
| TGTX | Buy | TG THERAPEUTICS INC | $7,163,000 | +96.9% | 148,620 | +112.5% | 1.78% | +34.4% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $6,659,000 | +27.4% | 257,086 | -0.8% | 1.65% | -13.0% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $6,608,000 | +484.8% | 321,101 | +684.9% | 1.64% | +299.8% |
| Buy | TRILLIUM THERAPEUTICS INC | $6,218,000 | +42.4% | 578,930 | +95.0% | 1.54% | -2.8% | |
| ACRS | New | ACLARIS THERAPEUTICS INC | $4,138,000 | – | 164,199 | +100.0% | 1.03% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $4,051,000 | – | 196,672 | +100.0% | 1.00% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $4,031,000 | +52.5% | 180,261 | +51.7% | 1.00% | +4.2% |
| INFI | New | INFINITY PHARMACEUTICALS INC | $3,911,000 | – | 1,210,863 | +100.0% | 0.97% | – |
| CASI | New | CASI PHARMACEUTICALS INC | $3,600,000 | – | 1,500,000 | +100.0% | 0.89% | – |
| BDTX | Buy | BLACK DIAMOND THERAPEUTICS I | $3,467,000 | +950.6% | 142,911 | +1289.8% | 0.86% | +616.7% |
| LSAQ | LIFESCI ACQUISITION II CORP | $3,042,000 | -5.0% | 300,000 | 0.0% | 0.75% | -35.2% | |
| AERI | New | AERIE PHARMACEUTICALS INCput | $2,502,000 | – | 140,000 | +100.0% | 0.62% | – |
| AERI | New | AERIE PHARMACEUTICALS INCcall | $2,502,000 | – | 140,000 | +100.0% | 0.62% | – |
| CYCC | New | CYCLACEL PHARMACEUTICALS INC | $2,086,000 | – | 293,419 | +100.0% | 0.52% | – |
| BLU | New | BELLUS HEALTH INC NEW | $1,460,000 | – | 380,237 | +100.0% | 0.36% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,449,000 | – | 160,256 | +100.0% | 0.36% | – |
| IMTX | New | IMMATICS N.V | $1,365,000 | – | 121,743 | +100.0% | 0.34% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $1,224,000 | – | 68,472 | +100.0% | 0.30% | – |
| EOLS | New | EVOLUS INC | $1,053,000 | – | 81,025 | +100.0% | 0.26% | – |
| AMRX | New | AMNEAL PHARMACEUTICALS INC | $939,000 | – | 139,470 | +100.0% | 0.23% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -14,557 | -100.0% | -0.02% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -15,618 | -100.0% | -0.02% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -17,260 | -100.0% | -0.05% | – |
| CPB | Exit | CAMPBELL SOUP CO | $0 | – | -4,432 | -100.0% | -0.08% | – |
| UL | Exit | UNILEVER PLCspon adr new | $0 | – | -3,725 | -100.0% | -0.08% | – |
| FLO | Exit | FLOWERS FOODS INC | $0 | – | -10,182 | -100.0% | -0.08% | – |
| TU | Exit | TELUS CORPORATION | $0 | – | -11,793 | -100.0% | -0.08% | – |
| BCE | Exit | BCE INC | $0 | – | -5,825 | -100.0% | -0.09% | – |
| CLX | Exit | CLOROX CO DEL | $0 | – | -1,234 | -100.0% | -0.09% | – |
| MKC | Exit | MCCORMICK & CO INC | $0 | – | -2,863 | -100.0% | -0.10% | – |
| K | Exit | KELLOGG CO | $0 | – | -4,416 | -100.0% | -0.10% | – |
| CHD | Exit | CHURCH & DWIGHT INC | $0 | – | -3,185 | -100.0% | -0.10% | – |
| GIS | Exit | GENERAL MLS INC | $0 | – | -4,799 | -100.0% | -0.10% | – |
| HSY | Exit | HERSHEY CO | $0 | – | -1,842 | -100.0% | -0.10% | – |
| HRL | Exit | HORMEL FOODS CORP | $0 | – | -6,148 | -100.0% | -0.10% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -3,631 | -100.0% | -0.11% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -1,695 | -100.0% | -0.11% | – |
| KMB | Exit | KIMBERLY-CLARK CORP | $0 | – | -2,291 | -100.0% | -0.11% | – |
| COST | Exit | COSTCO WHSL CORP NEW | $0 | – | -841 | -100.0% | -0.12% | – |
| VZ | Exit | VERIZON COMMUNICATIONS INC | $0 | – | -5,437 | -100.0% | -0.12% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -62,000 | -100.0% | -0.13% | – |
| CL | Exit | COLGATE PALMOLIVE CO | $0 | – | -4,343 | -100.0% | -0.14% | – |
| MDLZ | Exit | MONDELEZ INTL INCcl a | $0 | – | -6,608 | -100.0% | -0.14% | – |
| BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -9,630 | -100.0% | -0.16% | – |
| PG | Exit | PROCTER AND GAMBLE CO | $0 | – | -3,210 | -100.0% | -0.16% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -7,178 | -100.0% | -0.25% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -49,373 | -100.0% | -0.32% | – |
| TARA | Exit | PROTARA THERAPEUTICS INC | $0 | – | -39,225 | -100.0% | -0.34% | – |
| ARCT | Exit | ARCTURUS THERAPEUTICS HLDGS | $0 | – | -26,722 | -100.0% | -0.42% | – |
| CLRB | Exit | CELLECTAR BIOSCIENCES INC | $0 | – | -658,373 | -100.0% | -0.50% | – |
| ONCT | Exit | ONCTERNAL THERAPEUTICS INC | $0 | – | -285,714 | -100.0% | -0.51% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -19,832 | -100.0% | -0.62% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -728,710 | -100.0% | -0.95% | – |
| CRDF | Exit | CARDIFF ONCOLOGY INC | $0 | – | -157,403 | -100.0% | -1.03% | – |
| CRIS | Exit | CURIS INC | $0 | – | -360,697 | -100.0% | -1.07% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -56,402 | -100.0% | -1.11% | – |
| AXNX | Exit | AXONICS MODULATION TECHNOLOG | $0 | – | -64,378 | -100.0% | -1.17% | – |
| ALXO | Exit | ALX ONCOLOGY HLDGS INC | $0 | – | -39,226 | -100.0% | -1.23% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -56,003 | -100.0% | -1.56% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -40,159 | -100.0% | -1.68% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -67,384 | -100.0% | -2.13% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -121,409 | -100.0% | -2.52% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -271,974 | -100.0% | -2.63% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -23,374 | -100.0% | -2.73% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -73,906 | -100.0% | -3.01% | – |
| ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -62,235 | -100.0% | -3.06% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -166,077 | -100.0% | -3.73% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -54,105 | -100.0% | -4.00% | – |
| VTRS | Exit | VIATRIS INC | $0 | – | -1,046,794 | -100.0% | -7.12% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -193,223 | -100.0% | -7.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.